Editorial: Global excellence in inflammatory diseases: North America 2021.
作者信息
Kusner Linda L, Misra Ravi S, Lucas Rudolf
机构信息
The Laboratory for Myasthenia Gravis Research, Pharmacology and Physiology, The George Washington University, Washington, DC, United States.
Department of Pediatrics-Neonatology, University of Rochester-Golisano Children's Hospital, Rochester, NY, United States.
出版信息
Front Immunol. 2023 Jul 6;14:1245827. doi: 10.3389/fimmu.2023.1245827. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Global excellence in inflammatory diseases: North America 2021.社论：2021年北美地区在炎症性疾病领域的全球卓越表现
Front Immunol. 2023 Jul 6;14:1245827. doi: 10.3389/fimmu.2023.1245827. eCollection 2023.
2
Epidemiological evidence for a hereditary contribution to myasthenia gravis: a retrospective cohort study of patients from North America.遗传性因素对重症肌无力的影响的流行病学证据：来自北美的回顾性队列研究。
BMJ Open. 2020 Sep 18;10(9):e037909. doi: 10.1136/bmjopen-2020-037909.
3
Interstitial pneumonitis in myasthenia gravis.重症肌无力中的间质性肺炎。
Br J Dis Chest. 1984 Apr;78(2):187-91.
4
[Myasthenia gravis and muscle atrophy].重症肌无力与肌肉萎缩
Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(2):79-87. doi: 10.17116/jnevro202112102179.
5
Myasthenia gravis and associated autoimmune diseases in children.儿童重症肌无力及相关自身免疫性疾病
J Child Neurol. 2000 Nov;15(11):767-9. doi: 10.1177/088307380001501113.
6
Cigarette Smoking and Activities of Daily Living in Ocular Myasthenia Gravis.吸烟与眼肌型重症肌无力患者的日常生活活动
J Neuroophthalmol. 2016 Mar;36(1):37-40. doi: 10.1097/WNO.0000000000000306.
7
A genome-wide association study of myasthenia gravis.重症肌无力的全基因组关联研究。
JAMA Neurol. 2015 Apr;72(4):396-404. doi: 10.1001/jamaneurol.2014.4103.
8
Surgical and neurologic outcomes after robotic thymectomy in 100 consecutive patients with myasthenia gravis.100 例重症肌无力患者行机器人胸腺切除术的手术和神经学结果。
J Thorac Cardiovasc Surg. 2013 Mar;145(3):730-5; discussion 735-6. doi: 10.1016/j.jtcvs.2012.12.031. Epub 2013 Jan 11.
9
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.依库珠单抗治疗乙酰胆碱受体抗体阳性的难治性全身性重症肌无力（REGAIN）的安全性和有效性：一项 3 期、随机、双盲、安慰剂对照、多中心研究。
Lancet Neurol. 2017 Dec;16(12):976-986. doi: 10.1016/S1474-4422(17)30369-1. Epub 2017 Oct 20.
10
The role of B cell-activating factor in autoimmune myasthenia gravis.B 细胞激活因子在自身免疫性重症肌无力中的作用。
Ann N Y Acad Sci. 2012 Dec;1274:60-7. doi: 10.1111/j.1749-6632.2012.06842.x.
本文引用的文献
1
Editorial: Insights in inflammation: 2022.社论：炎症领域的见解：2022年。
Front Immunol. 2023 May 31;14:1224343. doi: 10.3389/fimmu.2023.1224343. eCollection 2023.
2
Editorial: Autoimmunity and Chronic Inflammation in Early Life.社论：生命早期的自身免疫与慢性炎症
Front Immunol. 2021 Sep 9;12:761160. doi: 10.3389/fimmu.2021.761160. eCollection 2021.
3
Editorial: Advances in Autoimmune Myasthenia Gravis.社论：自身免疫性重症肌无力的进展
Front Immunol. 2020 Aug 28;11:1688. doi: 10.3389/fimmu.2020.01688. eCollection 2020.
Zotero 插件